Jackson Financial Management Q3 2019 vs. Q4 2019: Comparing the Changes in Fund Holdings
Ava Hoppe | 14 May, 2023
The Q3 and Q4 2019 13F Holdings by Jackson Financial Management reveal the investment decisions made by the company during these quarters. As we delve deeper into the changes in holdings, we will analyze the companies invested in, the percentage ups and downs, and the reasons behind the movements.
One of the biggest shifts in holdings was the increase in Invesco, especially the Invesco Active ETF, which grew by 35.2% from Q3 to Q4 of 2019. Invesco Exchange Traded Funds also saw growth, with the Invesco Self-Indexed ETF increasing 5.8% and Invesco Exchange Traded Funds TR growing 6.4%.
Despite the overall growth in Invesco, some of its funds did experience a decline. The Invesco Gold Trust took the biggest dip, with a 3.8% decrease from Q3 to Q4. The Kayne Anderson MLP Midstream Investment also saw a decline in share value by 22.2%, from 741,475 to 598,722.
In contrast, the SPDR Gold Trust experienced a 3.8% decrease in the number of shares, from 110,110 to 102,945. Similarly, the Wright Medical Group saw a significant increase in the number of shares, from 0 to 19,480. However, the latter was not enough to increase the overall value of holdings.
The Ishares TR and Ishares US ETF's showed mixed results, with some of their investments, such as the Ishares TR increasing 23.4% while others, like the Ishares US ETF declining by 33.1%.
It was also remarkable that the INVESCO EXCH TRD SLF IDX FD, the Alpha Tec Holdings, and Atlantic Equities LLP were newly added to the holdings list in Q4 2019. Meanwhile, PSJ, Hologic Inc., and The Charles Schwab Corporation faced complete sellouts and were no longer in Jackson Financial Management's holdings list.
This comparison report shows that there has been diverse and strategic investment decision making at Jackson Financial Management. While they sold off some of their shares, they also increased others, making wise decisions to grow their portfolio. These movements indicate that, as an investor, it's important to watch the results of 13F filings closely and act accordingly to stay ahead of the game.
Other Posts
- Exploring the Winds of Change: How Raymond James & Associates Adjusted Their Sails in Early 2024
- Wells Trecaso Financial Group, LLC Q1 2023 vs. Q2 2023 13F Holdings Comparison
- Tortoise Capital Advisors Q3 vs. Q4 13F Holdings Comparison: Which Companies are Winning and Losing Investment?
- Greenwood Capital Associates LLC Q3 2022 vs. Q4 2022: A Comprehensive Review of 13F Holdings Changes
- Carisk® Partners: Elevating Workers' Compensation with Lee Equity and Elements Health Investors
- BCM Advisors, LLC Increases Holdings of Vanguard Consumer Staples ETF in Q1 2023
- Shore Capital Partners Expands Medical Device Portfolio with C2Dx Partnership and Cook Medical Acquisition
- P Schoenfeld Asset Management LP Q3 2022 vs. Q4 2022 13F Holdings Comparison
- Comparing Weitz Investment Management's Q3 2022 and Q4 2022 Holdings: The Ups and Downs of Top Stock Changes
- **Navigating Growth Waters: HKW's Latest Co-Captains and Their Voyage Towards Innovation**